Logical Exploration of Cinnamoyl-Containing Nonribosomal Peptides via Metabologenomic Targeting and Regulator Overexpression
A targeted method for discovering cinnamoyl-containing nonribosomal peptides (CCNPs), a unique class of bioactive compounds, was devised by using cinnamoyl isomerase, a key enzyme in the biosynthesis of the cinnamoyl moiety, as a genome mining probe. A total of 39 hit strains were obtained, including 35 from polymerase chain reaction-based screening of the in-house bacterial library (2.5% of 1400 strains) targeting the cinnamoyl isomerase-encoding gene and 4 from the genome mining of online databases. Sequence similarity networking and phylogenetic analyses of the isomerase amplicons (∼530 bp) classified the CCNPs into three major substructure-based groups (Z-, E-, and M-type CCNPs) and revealed distinct clade-structure relationships (13 clades). To overcome the challenge of silent biosynthetic gene clusters, we activated these clusters by overexpressing conserved cluster-situated LuxR regulators combined with extensive culture optimization. CCNP production was metabolomically detected in the bacterial extracts by using the characteristic UV absorption and MS/MS fragments of cinnamoyl moieties. CCNP production was observed in 20 of the 39 hit strains, resulting in the isolation of 6 new CCNPs, including oxy-skyllamycin B (<b>2</b>), gwanacinnamycin (<b>3</b>), and luxocinnamycins A-D (<b>4-7</b>), with high structural novelty. Their structures were elucidated using comprehensive spectroscopic analyses and multiple-step chemical derivatizations, and the putative biosynthetic pathways were bioinformatically proposed. Gwanacinnamycin (<b>3</b>) exhibited significant antimycobacterial activity, whereas luxocinnamycin A (<b>4</b>) displayed moderate antiproliferative activity against stomach cancer cells. Our findings highlight a targeted metabologenomic approach combined with transcriptional regulator overexpression as a logical and efficient platform for the discovery of bioactive compounds from nature.
Authors
- Dong‐Chan Oh (ORCID: https://orcid.org/0000-0001-6405-5535)
- Jichan Jang (ORCID: https://orcid.org/0000-0002-4598-5371)
- Joon Soo An (ORCID: https://orcid.org/0000-0002-3282-5790)
- Seung Bum Kim (ORCID: https://orcid.org/0000-0003-2279-5759)
- Thanh‐Hau Huynh (ORCID: https://orcid.org/0009-0002-5789-6621)
- Yejin Song
- Chae Won Ock (ORCID: https://orcid.org/0000-0002-0207-106X)
- Sung Chul Jang
- Sang Kook Lee (ORCID: https://orcid.org/0000-0002-4306-7024)
- Jayho Lee
- Yeo Joon Yoon (ORCID: https://orcid.org/0000-0002-3637-3103)
- Bo Eun Heo
- Ben Shen (ORCID: https://orcid.org/0000-0002-9750-5982)
- Jung Min Kim (ORCID: https://orcid.org/0000-0002-0983-9414)
- Sangwook Kang (ORCID: https://orcid.org/0009-0005-3060-3341)
Institutions
- Scripps Research Institute (US)
- Seoul National University (KR)
- Scripps Institution of Oceanography (US)
- Gyeongsang National University (KR)
- Chungnam National University (KR)
- Ono Pharmaceutical (United States) (US)
- Research Institute for Bioscience and Biotechnology (NP)
- Scripps (United States) (US)
- Health & Life (Taiwan) (TW)
- Molecular Discovery (United Kingdom) (GB)
- The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
- University of Montana (US)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1021/jacs.5c13143
- Citations
- 1
- Primary Topic
- Microbial Natural Products and Biosynthesis
- Type
- article
- Field-Weighted Citation Impact
- 1.39